Company intelligence
DermaSensor, Inc. - AI-Powered Skin Cancer Detection Device
America’s first FDA-cleared, skin cancer detection device. Clinically proven and trusted by Primary Care Physicians
Medical Equipment Manufacturing
Miami, US
39 employees
Founded 2009
2 public signals
About DermaSensor, Inc. - AI-Powered Skin Cancer Detection Device
Now cleared by the U.S. Food and Drug Administration (FDA), DermaSensor equips physicians with immediate, accurate, and objective results that improve skin cancer detection through data-driven breakthrough technologies.
Verified activity
Signals from DermaSensor, Inc. - AI-Powered Skin Cancer Detection Device
2 published signals
Presence & Recognition
DermaSensor, Inc. - AI-Powered Skin Cancer Detection Device was recognized by CIO Bulletin as a Leading Company to Watch in 2026.
Reported by DermaSensor, Inc. - AI-Powered Skin Cancer Detection Device
Partnerships
DermaSensor, Inc. - AI-Powered Skin Cancer Detection Device announced four new strategic partnerships to bring its AI-powered skin cancer technology to healthcare providers across the United States.
Reported by DermaSensor, Inc. - AI-Powered Skin Cancer Detection Device